drugset / Trial / NCT02672202
Shifting Pain Modulation From Pro-to Anti-nociceptive
RandomizedParallel-groupTriple-blindTreatment
Summary
To create a data base that will facilitate the enrichment of the insights regarding post-operative pain development, and to identify those individuals with the potential to develop this kind of pain. The identification will be based on the individualized pain modulation profile, composed of a battery of tests as detailed below.
Timeline
- Start
- 2016-02
- Primary completion
- 2017-05
- Completion
- 2017-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Duloxetine | Small molecule | 60 mg | — |
| Comparator | Pregabalin | Small molecule | 150 mg | — |